Integrated Platform Clario's consolidation of ERT and Bioclinica creates a single, end-to-end endpoint technology platform that covers clinical endpoints and medical imaging. This enables sponsors to consolidate vendors, streamline data capture and reporting, and accelerate trial timelines. Leverage this unified platform to upsell current clients and win new business with comprehensive trials.

Global Scale With a broad global footprint and enterprise-grade data governance, Clario can support multinational trials across regions with consistent quality, support, and regulatory readiness. The tech stack elements like Oracle Database and COBIT governance signal reliability for large sponsors. Target global pharma sponsors and long duration studies that require scalable, compliant data solutions.

AI-Driven Value Clario's platform is positioned to harness AI and advanced analytics to generate richer clinical evidence, real-time insights, and proactive risk monitoring. This supports modern trial designs and remote monitoring, offering opportunities for premium analytics services and imaging analytics.

Imaging Cross-Sell Bioclinica's imaging leadership paired with ERT's endpoint capabilities offers a unique cross-sell opportunity to existing imaging customers and endpoint users. Propose bundled offerings that combine imaging data interpretation, endpoint assessment, and integrated reporting to reduce vendor complexity for sponsors.

Strategic Partnerships The strong market position and large scale suggest a strategic co-sell approach with leading CROs and pharmaceutical sponsors seeking an integrated platform. Build partnerships with CRO networks and global pharma accounts to expand adoption, shorten procurement cycles, and drive renewals through a single, end-to-end solution.